Source: Massachusetts General Hospital
Date: September 13, 2006
Summary:
Magnetic resonance imaging (MRI) with an approved contrast agent may provide a practical way of monitoring the survival of transplanted pancreatic islets. Researchers report successfully tracking over time the fate of islets transplanted into mice using a protocol currently being tested in human patients.
Commentary: Hopefully this new advance will enable safe and effective cell therapy treatments for patients with diabetes.
No comments:
Post a Comment